Fred Upton bought Biogen Inc (NASDAQ: BIIB)
Fred Upton (R-MI), a U.S. Representative, has disclosed 1 trade in Biogen Inc (BIIB) since 2020, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Fred Upton bought $1,001 - $15,000 of Biogen Inc (NASDAQ: BIIB) on March 8, 2020. Since that trade, BIIB is down -34.19% against the S&P 500 up +168.35%, an outperformance of -202.54%.
Data updated
Fred Upton's BIIB trades vs the price
BIIB is down -34.19% since Fred Upton bought on March 8, 2020, versus +168.35% for the S&P 500.
Performance since this trade
All Fred Upton BIIB trades
Fred Upton & BIIB trading FAQ
Is it legal for Fred Upton to trade Biogen Inc (BIIB) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Biogen Inc (BIIB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Fred Upton buy BIIB?
Fred Upton disclosed a purchase of $1,001 - $15,000 of Biogen Inc (BIIB) on March 8, 2020, according to public STOCK Act filings.
How has BIIB performed since Fred Upton's trade?
Since Fred Upton bought BIIB on March 8, 2020, the stock is down -34.19%, versus +168.35% for the S&P 500 over the same period, an outperformance of -202.54%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BIIB trades?
Quantellect tracks every disclosed congressional trade in Biogen Inc (BIIB) on the Biogen Inc congressional trading page, which aggregates filings across all members of Congress.
Fred Upton's BIIB tradesAll congressional filings for Biogen IncFred Upton's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.